Related Experiment Videos
Experimental murine infection with the diffuse cutaneous leishmaniasis strain, Isabel
B A Shaw1, J B Grayson, E A Petersen
1University of Arizona Health Sciences Center, Section of Infectious Disease, Tucson 85724.
Annals of Tropical Medicine and Parasitology
|February 1, 1987
Summary
This study details leishmaniasis progression in various mouse strains, identifying BALB/c mice as susceptible. This model aids research into early immunological events of leishmaniasis.
Area of Science:
- Immunology
- Parasitology
- Infectious Diseases
Background:
- Leishmaniasis is a complex parasitic disease with varied host responses.
- Understanding host-parasite interactions is crucial for developing effective treatments.
- Inbred mouse models are essential for dissecting the genetic basis of disease susceptibility.
Purpose of the Study:
- To characterize the susceptibility of different inbred mouse strains to Leishmania infection.
- To establish a long-term mouse model for studying the progression of leishmaniasis.
- To identify key parameters for assessing disease severity and host response.
Main Methods:
- Infection of multiple inbred mouse strains with the Isabel strain of Leishmania.
- Quantification of parasite burden in footpad lesions, spleen, and lymph nodes.
- Assessment of metastatic lesion development over an extended period.
Main Results:
- Mouse strains were categorized into susceptible (BALB/c, BALB.B, SWR/J), intermediate (DBA/1J), and resistant (C57BL/6, C57BL/10, DBA/2J, B10.D2) groups.
- BALB/c mice, previously characterized for Leishmania infections, were selected for detailed progression studies.
- Parasite load and metastatic lesions were monitored to evaluate disease progression.
Conclusions:
- The characterized mouse model provides a valuable platform for investigating early immunological events in leishmaniasis.
- Differential susceptibility among mouse strains highlights the genetic influence on Leishmania infection outcomes.
- This model facilitates research into the pathogenesis and immune response to Leishmania.